GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Voyageur Pharmaceuticals VM.V · CAD

N/A · TSX Venture · 🇨🇦 Canada

Compare

0.14

+12.50%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Voyageur Pharmaceuticals — daily TSXV:VM Delayed
Market value
C$24.1m
Last close × shares
Volume
183.9k
Shares, 9 Nov 2026

About Voyageur Pharmaceuticals

Its shares trade on TSX Venture under the ticker VM.V. It has been listed since 18 May 2012. In the fiscal year to 30 November 2025, it reported revenue of C$11,685 and a net loss of C$3.5m. At that date it held total assets of C$3.1m and shareholders' equity of C$1.3m.

Voyageur Pharmaceuticals Ltd. engages in exploring and development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. The company is headquartered in Calgary, Alberta. The company went IPO on 2012-05-18. The firm is focused on the development of barium, iodine and carbon active pharmaceutical ingredients (API) and high-performance imaging contrast agents for the medical imaging marketplace. The firm owns a 100% interest in three barium sulfate (barite) projects, including the Frances Creek property, suitable in grade for the pharmaceutical marketplace, with additional interests in a high-grade iodine, lithium & bromine brine project located in Utah, United States of America. The Company’s product pipeline includes SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101, and VY-103.

Figures and description from our data supplier, not checked against the company's own report.

More about Voyageur Pharmaceuticals →

Latest on Voyageur Pharmaceuticals

Our reporting

We have not reported on Voyageur Pharmaceuticals yet.

Next results

1 Apr 2027

Due on 1 Apr 2027.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Voyageur Pharmaceuticals's ticker?

Voyageur Pharmaceuticals trades as VM.V on TSX Venture, under ISIN CA92918C1014.

What was Voyageur Pharmaceuticals's last closing price?

0.14 on 9 Nov 2026. The figure is in CAD and is never converted.

When does Voyageur Pharmaceuticals next report results?

Results are expected on 1 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.